Mechanisms of cancer cell death induction by triptolide: A comprehensive overview

Area of Science:

• Natural Products Chemistry
• Cancer Biology
• Pharmacology

Background:

• Rising cancer prevalence necessitates novel therapeutic agents with fewer side effects than traditional chemotherapeutics.
• Triptolide, derived from Tripterygium Wilfordii, is a key natural compound with significant anti-cancer potential.
• Understanding triptolide's molecular mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

• To explore the biological mechanisms and therapeutic potential of triptolide against various tumors.
• To identify key molecular targets and pathways modulated by triptolide in cancer cells.
• To evaluate the efficacy of triptolide in combination with existing chemotherapeutics and assess novel delivery strategies.

Main Methods:

• Pre-clinical investigations analyzing triptolide's effects on cancer cell apoptosis.
• Identification of molecular targets including heat shock protein 70 (HSP70), cyclin-dependent kinases (CDKs), and others like MKP1, histone methyl transferases, and RNA polymerases.
• Exploration of triptolide's impact on cellular pathways such as autophagy and AKT signaling, and its interactions with proteins like ADAM10, PC-2, DCTP1, Prx-I, TAB1, DNA-PKcs, and XPB.
• Assessment of triptolide's synergistic effects with chemotherapeutics and investigation of targeted delivery systems (ligand conjugation, nano-carriers).

Main Results:

• Triptolide induces cancer cell death by promoting apoptosis through inhibition of HSP70 and CDKs, and up-regulation of P21.
• Identified multiple molecular targets and signaling pathways affected by triptolide, including autophagy, AKT, and various protein interactions.
• Demonstrated triptolide's ability to enhance the effectiveness of conventional chemotherapeutics.
• Showcased the potential of targeted strategies like ligand conjugation and nano-carriers to mitigate triptolide's toxicities.

Conclusions:

• Triptolide exhibits significant anti-cancer properties through diverse molecular mechanisms, including apoptosis induction and modulation of key cellular pathways.
• Triptolide shows promise as an adjunct therapy, enhancing the efficacy of existing cancer treatments.
• Targeted delivery systems and combination therapies involving triptolide are crucial for optimizing its therapeutic index and future clinical application.